A Singapore-based company, Union Yoga Ayurveda, was fined S$15,000 (US$11,730) on Thursday, May 28, following a court appearance regarding the sale of medicinal pills found to contain dangerous levels of lead. The firm pleaded guilty to three charges under the Medicines Act for selling products that exceeded permissible lead limits, with an additional six charges taken into consideration during sentencing.
The Path to Prosecution
The investigation into the company began after the Health Sciences Authority (HSA) received a medical report on October 16, 2024, from Tan Tock Seng Hospital. A female patient, who had sought an ayurvedic consultation at the company’s Kembangan branch, presented with severe symptoms including fatigue, chest discomfort, and shortness of breath. She was subsequently diagnosed with anaemia resulting from lead poisoning and required hospitalisation.
Following the report, authorities seized bottles of the product, known as Mahayograj Guggulu, from the Kembangan branch in November 2024. The company later surrendered remaining stock during a product recall. Testing conducted by the HSA revealed that the pills contained lead levels exceeding safety limits for traditional medicines by thousands of times.
The Risks of Heavy Metal Exposure
Lead is a toxic heavy metal that poses significant health risks. According to the HSA, acute exposure can lead to abdominal pain, vomiting, nausea, liver inflammation, brain injury, and anaemia. Long-term exposure is known to cause systemic damage to the kidneys, as well as the digestive and nervous systems.
The impact of the company’s actions extended beyond the initial hospitalised patient. Following a public warning issued by the HSA, a mother contacted authorities after her daughter showed signs of low haemoglobin; the daughter was subsequently diagnosed with high lead intoxication. In total, the company had sold hundreds of bottles to 37 customers over a nine-month period between February and November 2024.
Looking Ahead
While the company has been fined for the charges brought against it, the broader implications for the firm remain uncertain. A representative for the company characterized the incident as “a mistake” during the mitigation process. Moving forward, further health monitoring may be required for the remaining customers who purchased the product, and the company may face increased scrutiny regarding their future procurement and testing protocols for medicinal imports.
Frequently Asked Questions
What product was identified as containing dangerous levels of lead?
The product identified was an ayurvedic pill called Mahayograj Guggulu.
How many people were affected by the pills?
Out of 37 customers who purchased the pills, two have been reported to have suffered from adverse health effects related to lead exposure.
What is the maximum penalty the company could have faced?
The company could have been fined up to S$5,000 for each of the three charges of selling a medicinal product exceeding the allowed quantity of lead.
How do you verify the safety of traditional or alternative medicinal products before you use them?
Related reading